| lidocaine 5% / Generic mfg. |
2009-010557-12: Comparison of Lidocaine 5% plasters and Pregabalin for the treatment of the painful condition called Complex Regional Pain Syndrome. |
|
|
| Ongoing | 4 | 20 | Europe | Lidocaine 5% Plaster, pregabalin, Medicated plaster, Capsule, hard, Versatis 5% Medicated Plaster, Lyrica | The Pennine Acute Hospitals NHS Trust, The Pennine Acute Hospitals NHS Trust | Complex regional pain syndrome type 1., Complex Regional Pain Syndrome, also called as Reflex Sympathetic Dystrophy or Sudeck's atrophy is a chronic painful condition often affecting an arm or leg with skin changes and swelling, Diseases [C] - Nervous System Diseases [C10] | | | | |
2009-013706-13: ANALGESIC RESPONSE TO TRANSDERMAL LIDOCAINE IN PATIENTS WITH PAINFUL PERIPHERAL DIABETIC NEUROPATHY UNDERLYING DIFFERENT SENSORY PATTERNS |
|
|
| Ongoing | 4 | 60 | Europe | Versatis, LS-001775, Versatis, Versatis | Wilhelminenspital der Stadt Wien | In this study the effect of transdermal lidocaine in patients with painful peripheral diabetic neuropathy will be examined. | | | | |
2018-003617-17: Localized neuropathic pain: topical treatment versus systemic treatment |
|
|
| Not yet recruiting | 4 | 591 | Europe | Cutaneous patch, Capsule, hard, Lidocaïne Grünenthal 700 mg pleister (Versatis), Capsaicine (Qutenza) 179 mg huidpleister, Pregabaline (Lyrica) 75 mg harde capsules | Antwerp University Hospital (UZA), Belgian Health Care Knowledge Center (KCE) | Patients suffering from localized neuropathic pain (LNP), Patients suffering from localized neuropathic pain (LNP), Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT05834647: Efficacy and Safety of Prilocaine 2% and Lidocaine 5% Hyperbaric Against Spinal Anesthesia in Post Cystoscopy Procedure |
|
|
| Not yet recruiting | 4 | 45 | NA | Prilocaine 2%, Takipril, Hyperbaric Lidocaine 5%, Lidodex | Universitas Sebelas Maret, Indonesia Endowment Fund for Education | Anesthesia; Reaction, Anesthesia | 11/23 | 12/23 | | |
NCT03968822: Intralipid® 20% for Reversal of Local Anesthetics |
|
|
| Recruiting | 4 | 18 | US | Lidocaine 2%, Lidocaine Viscous, Lidoderm, Recticare, Lidocaine 1%, Bupivacaine 0.25%, Marcaine, Sensorcaine, Bupivacaine 0.5%, Intralipid, 20% Intravenous, i.v. fat emulsion, Saline intravenously, salt, Saline | Hospital for Special Surgery, New York | Anesthesia, Local | 10/24 | 10/25 | | |
PE, NCT04703127: Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. |
|
|
| Recruiting | 3 | 60 | RoW | Tadalafil and Combined Dapoxietine, Tadalafil with Combined Dapoxietine, Dapoxietine and Combined Lidocaine 5% Spray, Dapoxietine With Lidocaine 5% Spray | Sohag University | Premature Ejaculation | 01/21 | 01/21 | | |
EASY, NCT04169854: Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain |
|
|
| Recruiting | 3 | 180 | RoW | Lidocaine 5% patch, Placebo patch | Beijing Tiantan Hospital | Postoperative Pain, Lidocaine | 01/23 | 01/23 | | |
2011-002083-25: Is there a correlation between the pain relief and the A-delta- and C-fiber function after topical application of lidocaine (5%) in patients with peripheral neuropathic pain? Korreliert die Schmerzlinderung mit der A-Delta-und C-Faser-Funktion nach topischer Lidocain-Applikation (5%) bei Patienten mit peripheren neuropathischen Schmerzen? |
|
|
| Ongoing | 2 | 30 | Europe | Versatis, Versatis | BG University Hospital Bergmannsheil GmbH | Patients with proven diagnosis of painful peripheral neuropathic pain syndromes as diagnosed as:1. Peripheral nerve lesion or2. Postherpetic neuralgia. | | | | |
2016-000864-41: Effect of a lidocaine patch in the reduction of the lower limb amputation pain. |
|
|
| Ongoing | 2 | 20 | Europe | Cutaneous patch, Versatis 5% | Centre Hospitalier Universitaire Brugmann, CHU Brugmann | Lower limb amputation pain: phantom limb pain and primary/secondary scar hyperalgesia., Lower limb aputation pain., Body processes [G] - Bones and nerves physological processes [G11] | | | | |
2016-002611-18: Lidocaine/diclofenac epolamine patch (GRT7019) Phase II proof-of-concept trial in patients with chronic pain due to knee osteoarthritis. |
|
|
| Ongoing | 2 | 300 | Europe | Lidocaine 700 mg / Diclofenac epolamine 182 mg Patch, GRT7019, Medicated plaster, Modified-release tablet, Gastro-resistant tablet, Versatis 5% medicated plaster, Diclo 75 SL - 1A Pharma, Pantoprazol-ratiopharm 20 mg | Grünenthal GmbH, Grünenthal GmbH | osteoarthritis, osteoarthritis, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |
NCT06312254: Pharmacological Modulation of Peripheral Nerve Excitability |
|
|
| Not yet recruiting | N/A | 20 | Europe | Topical lidocaine 5%, Topical Phenytoin 10%, Topical Mepyramine 2%, Topical Placebo | Aalborg University | Peripheral Neuropathy | 02/25 | 08/25 | | |